Art. 34 Directive (EU) 2001/83

In forcesince 16 Nov 2012cited 30×
1.

The Commission shall take a final decision in accordance with, and within 15 days after the end of, the procedure referred to in Article 121(3).

2.

The rules of procedure of the Standing Committee established by Article 121(1) shall be adjusted to take account of the tasks incumbent upon it under this Chapter.

Those adjustments shall entail the following provisions:

(a)

except in cases referred to in the third paragraph of Article 33, the opinion of the Standing Committee shall be given in writing;

(b)

Member States shall have 22 days to forward their written observations on the draft decision to the Commission. However, if a decision has to be taken urgently, a shorter time-limit may be set by the Chairman according to the degree of urgency involved. This time-limit shall not, otherwise than in exceptional circumstances, be shorter than 5 days;

(c)

Member States shall have the option of submitting a written request that the draft Decision be discussed in a plenary meeting of the Standing Committee.

Where, in the opinion of the Commission, the written observations of a Member State raise important new questions of a scientific or technical nature which have not been addressed in the opinion delivered by the Agency, the Chairman shall suspend the procedure and refer the application back to the Agency for further consideration.

The provisions necessary for the implementation of this paragraph shall be adopted by the Commission in accordance with the procedure referred to in Article 121(2).

3.

The decision as referred to in paragraph 1 shall be addressed to all Member States and reported for information to the marketing authorisation holder or applicant. The concerned Member States and the reference Member State shall either grant or revoke the marketing authorisation, or vary its terms as necessary to comply with the decision within 30 days following its notification, and they shall refer to it. They shall inform the Commission and the Agency accordingly.

Where the scope of the procedure initiated under Article 31 includes medicinal products authorised in accordance with Regulation (EC) No 726/2004 pursuant to the third subparagraph of Article 31(2) of this Directive, the Commission shall, where necessary, adopt decisions to vary, suspend or revoke the marketing authorisations or to refuse the renewal of the marketing authorisations concerned.

The 10 that are cited most themselves, of 30.

  • Directive (EU) 2004/27Lawamends

  • Arrêt du Tribunal (cinquième chambre) du 11 décembre 2014. PP Nature-Balance Lizenz GmbH contre Commission européenne.Decision

    … premièrement, il y a lieu de rappeler que la Commission a adopté la décision attaquée sur le fondement de l’article 34, paragraphe 1, de la directive 2001/83, à la suite de la saisine du comité par la République fédérale …

    11 Dec 2014 · 62013TJ0189

  • Gesetz über den Verkehr mit Arzneimitteln25b3039Law

    … (5) Bei einer abweichenden Entscheidung bezüglich der Zulassung, ihrer Aussetzung oder Rücknahme finden die Artikel 30, 32, 33 und 34 der Richtlinie 2001/83/EG Anwendung. Im Falle einer Entscheidung nach Artikel 34 der Richtlinie …

  • Geneesmiddelenwet55Law

    1. De artikelen 44, derde, vierde en vijfde lid, en 46, derde en vierde lid, van deze wet alsmede de artikelen 32, 33 en 34 van richtlijn 2001/83 zijn niet van toepassing op kruidengeneesmiddelen als bedoeld in artikel 42, achtste lid, …

  • Judgment of the Court (First Chamber) of 16 October 2008. The Queen, on the application of Synthon BV v Licensing Authority of the DepartmenDecision

    In the course of those proceedings, the H igh Court of Justice of England and Wales, Queen’s Bench Division (Administrative Court) decided to stay the proceedings and refer the following questions to the Court for a preliminary …

    16 Oct 2008 · 62006CJ0452

  • Arrêt de la Cour (huitième chambre) du 3 décembre 2015. PP Nature-Balance Lizenz GmbH contre Commission européenne.Decision

    L’article 34 de cette directive prévoit: «1. La Commission arrête une décision définitive conformément à la procédure visée à l’article 121, paragraphe 3, et dans les quinze jours qui suivent la fin de celle-ci.

    3 Dec 2015 · 62015CJ0082

  • Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…29Law

    … може да бъде подадено в съответствие с процедурата, установена в членове 32, 33 и 34 от Директива 2001/83/ЕО, когато се иска разрешително …

  • Regeling Geneesmiddelenwet3.5aLaw

    … Als de Commissie ter afsluiting van de arbitrageprocedure, bedoeld in de artikelen 32, 33 en 34 van richtlijn 2001/83, een eindbeschikking heeft vastgesteld neemt het College artikel 34, derde lid, in acht.

  • Code de la santé publiquer5121-51-5r5121-51-8Law

    A défaut d'accord au sein du groupe de coordination, la procédure d'arbitrage communautaire prévue aux articles 32 à 34 de la directive 2001/83/ CE du Parlement européen et du Conseil s'applique. Lorsque la France est l'Etat de …

  • Judgment of the Court (Fourth Chamber) of 27 March 2019. Dr. August Wolff GmbH & Co. KG Arzneimittel and Remedia d.o.o. v European CommissioDecision

    Article 34(1) of the directive reads as follows: ‘The Commission shall take a final decision in accordance with, and within 15 days after the end of, the procedure referred to in Article 121(3).’

    27 Mar 2019 · 62016CJ0680